uridine triphosphate has been researched along with Arrhythmias, Cardiac in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belosludtseva, NV; Bulion, VV; Evdokimova, NR; Krylova, IB; Mironova, GD; Rodionova, OM; Selina, EN; Shigaeva, MI | 1 |
| Alvarez, J; Bideaux, P; Boulay, G; Cazorla, O; Coulombe, A; Fauconnier, J; Lacampagne, A; Magyar, J; Mathieu, EL; Rassendren, F; Rauzier, JM; Salazar, G; Souto, R; Ugur, M; Vassort, G | 1 |
2 other study(ies) available for uridine triphosphate and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Uridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia/reperfusion by activating the mitochondrial ATP-dependent potassium channel.
Topics: Acute Disease; Adenosine Triphosphate; Animals; Antioxidants; Arrhythmias, Cardiac; Disease Models, Animal; Lipid Peroxidation; Male; Myocardial Reperfusion Injury; Myocardium; Potassium Channels; Rats, Wistar; Tachycardia; Uridine; Uridine Diphosphate; Uridine Triphosphate; Ventricular Fibrillation | 2021 |
ATP/UTP activate cation-permeable channels with TRPC3/7 properties in rat cardiomyocytes.
Topics: Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Cell Membrane Permeability; Disease Models, Animal; Dogs; Estrenes; Humans; Male; Membrane Potentials; Mice; Mice, Knockout; Myocardial Infarction; Myocytes, Cardiac; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Phospholipase C beta; Pyrrolidinones; Rats; Rats, Wistar; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2X4; Receptors, Purinergic P2Y2; Signal Transduction; TRPC Cation Channels; Uridine Triphosphate | 2008 |